Navigation Links
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Date:10/11/2007

sor of medicine and director of the Center for Intestinal Health & Nutrition Support, University of Pittsburgh Medical Center, said, "Judging from these top-line results, teduglutide is an exciting new treatment option for our patients with intestinal failure due to massive intestinal loss. We eagerly await the peer review and publication of the full results of this international, multi-center clinical trial to determine the specific indications for this new therapeutic advance."

In this Phase 3 study, there were no statistical differences in the incidence rates of adverse events or serious adverse events among the treatment groups when compared to placebo.

The study's Data Safety Monitoring Board (DSMB) found that GATTEX was generally well tolerated and demonstrated clinical benefits. Additionally, the DSMB supported the company's recommendation to continue the ongoing extension study. Ninety-two percent (92%) of the 71 patients who completed the Phase 3 trial enrolled in the extension study.

Dr. Tony Coles, president and CEO of NPS, stated: "The results of the study underline the importance of GATTEX as a potential new standard of care for SBS. We are particularly encouraged to see a reduction in PN over six months in patients with SBS who received the lower dose of GATTEX. Patients who responded to this dose were able to reduce their reliance on parenteral nutrition by over 20%, which represents a clinically meaningful benefit, and we are very excited that two of the 35 patients on the lower dose were able to eliminate their PN entirely by week 20, and a third patient was also able to stop PN altogether at week 24. We look forward to presenting these findings at an upcoming medical meeting and further exploring the full range of clinical benefits of GATTEX. We remain committed to making GATTEX available to patients as soon as possible and intend to meet with regulatory agencies to discuss next steps for regulatory approval. We also plan to conti
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...   BioClinica®, Inc ., a specialty clinical ... it has acquired a leading global patient recruitment ...  The acquisition includes affiliates MediciGlobal , Ltd. ... a lost-to-follow-up patient locate service ( L2FU®) ... BioClinica will offer pharmaceutical companies comprehensive ...
(Date:7/6/2015)... Hologic, Inc. (NASDAQ: HOLX ) announced ... results for the third quarter of fiscal 2015 on ... conjunction with the release, management will host a conference ... Interested participants may listen to the call by ... ) or 719-325-4804 (for international callers) and referencing access ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, 2015 ... biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ... need and commercial potential, today announced that it ... E warrants to purchase 21,917,808 shares of its ... 2,191,781 shares of its common stock.  Certain funds ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
(Date:7/6/2015)... ... 06, 2015 , ... Promero, a leading cloud hosting provider ... IP contact center solution hosted by Promero. Randstad Technologies,a leading talent and ... call center platform. , Promero will implement and manage the private cloud ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Diabetes affects ... help. More than 29 million Americans have diabetes, the majority of which are Type ... U.S. adults or more than one in three, have prediabetes (abnormally high blood sugar ...
(Date:7/6/2015)... ... 06, 2015 , ... The Path of Least Resistance: The Evolution of Capitalism ... the U.S. economy over the past 40 years. The book explores the evolution of ... the book is a time capsule that chronicles the economic development of the United ...
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty sporting ... two training clinics for first-time triathletes this summer with ethos, the owner and operator ... Thursday, July 9, at 6:00 p.m. at the North End Greenway. The event will ...
(Date:7/5/2015)... ... July 05, 2015 , ... World Patent Marketing, a vertically ... invention that effectively removes weeds without harming man and nature. , "The ... and Creative Director of World Patent Marketing. "It is projected to grow at ...
Breaking Medicine News(10 mins):Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5
... State University) and colleagues uncover a stem-cell specific role ... the developing mammalian embryo. ,Researchers had ... embryos. Using a combination of sophisticated mouse genetics and ... Rb is required for the maintenance of the trophoblast ...
... the the journal SLEEP, sleep-disturbed children are more severely ... disorders compared with children without sleep disturbance. ... sleep-disturbed children are advised to first consult with the ... sleep specialist for comprehensive testing and treatment. ...
... Scientists at the National Institute of Arthritis and Musculoskeletal ... of Health in Bethesda, Md., and colleagues at the ... in unprecedented detail, the virus that causes influenza. ... Steven, Ph.D., working with a version of the seasonal ...
... implicated in the onset of human puberty also ... rodents, report Indiana University Bloomington and// University of ... Endocrinology. The paper is now accessible online via ... ,The researchers present evidence that kisspeptin, a recently ...
... gene prevents the production of a critical blood-clotting protein. ... they exist//, may consist of risky blood transfusions or ... could be induced to begin producing these proteins, say ... lacking? ,Prof. Yair Reisner and Ph.D. student Anna ...
... and their collaborators are gaining widespread attention for discoveries ... babies to AIDS patients. ,Their findings about ... major scientific journals. Nature published a paper in its ... often you get such a cluster of papers coming ...
Cached Medicine News:Health News:Link Between Insomnia and Hypersomnia, Depression in Children 2Health News:Molecular Anatomy of Influenza Virus Detailed 2Health News:Sex Ends as Seasons Shift and Kisspeptin Levels Plummet 2Health News:Sex Ends as Seasons Shift and Kisspeptin Levels Plummet 3Health News:A Transplant in Time - Scientists ID Window for Tissue Transplant 2Health News:Findings on Dangerous Parasite, Toxoplasma Gondii Published 2
Intermittent catheter...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Disease diagnosis and treatment reference sourced from Griffith's 5-Minute Clinical Consult. Save time diagnosing and treating more than 1,200 diseases and conditions....
... Flexible Band is a flexible partial ... alternative for surgeons who desire posterior ... Tailor® Annuloplasty Ring, which is designed ... rings, but like the option of ...
Medicine Products: